Interhospital transfer linked to treatment delays, worse outcomes in stroke patients
Patients who were moved between hospitals before receiving endovascular therapy were more likely to experience adverse clinical outcomes.
TRANSFORM-HF team pioneers new type of clinical trial
Heart failure patients have a tendency to accumulate excess fluid in the body, which can lead to debilitating symptoms such as shortness of breath and swelling. Loop diuretic medication, aims to prevent accumulation of this fluid and is the cornerstone treatment for heart failure signs and symptoms. With more than six million Americans affected by heart failure, and about one million hospitalized every year, a new DCRI study called TRANSFORM-HF will directly compare two well-known diuretics – furosemide and torsemide – to determine which is the most effective.